Lymphatic Filariasis: Clinical Trials

1 trial for Lymphatic Filariasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Withdrawn 1

Follow Lymphatic Filariasis: new trials by email Literature Review of Lymphatic Filariasis trials Research Report on Lymphatic Filariasis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis
azithromycin, ivermectin, albendazole - Trachoma, Lymphatic Filariasis
Phase 4WithdrawnEmory University2014-02-012014-05-22

Narrower conditions

Elephantiasis, Filarial (1)  ·  Neglected Diseases (1)  ·  Trachoma (1)

Broader conditions

Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Chlamydia Infections (1)  ·  Chlamydiaceae Infections (1)  ·  Conjunctival Diseases (1)  ·  Conjunctivitis (1)  ·  Conjunctivitis, Bacterial (1)  ·  Corneal Diseases (1)  ·  Disease Attributes (1)  ·  Eye Diseases (1)  ·  Eye Infections (1)  ·  Eye Infections, Bacterial (1)  ·  Filariasis (1)  ·  Gram-Negative Bacterial Infections (1)  ·  Helminthiasis (1)

Interventions

Albendazole (1)  ·  Azithromycin (1)  ·  Ivermectin (1)

Sponsors

Emory University (1)

Countries

Mozambique (1)

Top investigators

Huub C Gelderblom, MD, PhD, MPH (1)  ·  Ricardo Thompson, PhD (1)